NHE1, the principal target of CHP1, confers resistance to apoptosis and loss of NHE1, a neuronal plasma membrane constituent of the hippocampus and cortex, increases central nervous system excitability and produces epilepsy [87, 88, 90]. This evidence concerns the gene SLC9A1 and epilepsy.